首页 | 本学科首页   官方微博 | 高级检索  
     


Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
Authors:Payan C  Roudot-Thoraval F  Marcellin P  Bled N  Duverlie G  Fouchard-Hubert I  Trimoulet P  Couzigou P  Cointe D  Chaput C  Henquell C  Abergel A  Pawlotsky J M  Hezode C  Coudé M  Blanchi A  Alain S  Loustaud-Ratti V  Chevallier P  Trepo C  Gerolami V  Portal I  Halfon P  Bourlière M  Bogard M  Plouvier E  Laffont C  Agius G  Silvain C  Brodard V  Thiefin G  Buffet-Janvresse C  Riachi G  Grattard F  Bourlet T  Stoll-Keller F  Doffoel M  Izopet J  Barange K  Martinot-Peignoux M  Branger M  Rosenberg A  Sogni P  Chaix M L  Pol S  Thibault V  Opolon P  Charrois A  Serfaty L  Fouqueray B  Grange J D  Lefrère J J  Lunel-Fabiani F
Affiliation:Laboratoire de Virologie, CHU Angers, France. chpayan@chu-angers.fr
Abstract:Summary.  This cross-sectional study aimed to investigate, during a short period between 2000 and 2001, in a large population of patients with chronic hepatitis C, the epidemiological characteristics of hepatitis C virus (HCV) genotypes in France. Data from 26 referral centres, corresponding to 1769 patients with chronic hepatitis C were collected consecutively during a 6-month period. HCV genotyping in the 5'-non-coding region (NCR) was performed in each center using the line probe assay (LiPA, in 63% of cases), sequencing (25%) or primer-specific polymerase chain reaction (PCR) (12%). HCV genotypes 1a, 1b, 2, 3, 4, 5, non-subtyped 1 and mixed infection were found in 18, 27, 9, 21, 9, 3, 11 and 1% of our population, respectively. HCV genotype distribution was associated with gender, age, source and duration of infection, alanine aminotransferase (ALT) levels, cirrhosis, alcohol consumption, hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection. In multivariate analysis, only the source of infection was the independent factor significantly associated with genotype ( P  = 0.0001). In conclusion, this study shows a changing pattern of HCV genotypes in France, with i.v. drug abuse as the major risk factor, an increase of genotype 4, and to a lesser extent 1a and 5, and a decrease of genotypes 1b and 2. The modification of the HCV genotype pattern in France in the next 10 years may require new therapeutic strategies, and further survey studies.
Keywords:epidemiology    evolution    HCV genotypes    pathogenicity    treatment
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号